Remdesivir only for restricted emergency use on Covid-19 patients: Govt

The Union health ministry issued a fresh clinical management protocol for Covid-19 patients on Friday

The Union health ministry on Friday revised the dosage of the antiviral drug remdesivir, being administered to hospitalised coronavirus (Covid-19) patients, from the earlier six days to a five-day treatment course.

According to the ministry, the remdesivir drug is only for restricted emergency use on patients with moderate disease (those on oxygen support). The drug cannot be administered to a pregnant or lactating mother and children below the age of 12 years. Also, the drug is not recommended for patients with severe renal impairment or a high level of liver enzymes.

In the fresh clinical management protocol for Covid-19 patients